Inventiva S.A. (IVA)
NASDAQ: IVA · Real-Time Price · USD
4.780
-0.060 (-1.24%)
Sep 4, 2026, 4:00 PM EDT - Market closed
Inventiva Revenue
In the year 2025, Inventiva had annual revenue of 7.93M EUR, down -46.17%. Inventiva had revenue of 2.32M in the half year ending December 31, 2025, a decrease of -86.00%.
Revenue (ttm)
7.93M EUR
Revenue Growth
-46.17%
P/S Ratio
140.44
Revenue / Employee
102,935 EUR
Employees
77
Market Cap
1.11B USD
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 7.93M | -6.80M | -46.17% |
| Dec 31, 2024 | 14.72M | -8.44M | -36.43% |
| Dec 31, 2023 | 23.16M | 4.35M | 23.12% |
| Dec 31, 2022 | 18.81M | 10.31M | 121.32% |
| Dec 31, 2021 | 8.50M | 3.24M | 61.52% |
| Dec 31, 2020 | 5.26M | -6.03M | -53.39% |
| Dec 31, 2019 | 11.29M | 3.91M | 53.02% |
| Dec 31, 2018 | 7.38M | -2.58M | -25.90% |
| Dec 31, 2017 | 9.96M | -4.39M | -30.61% |
| Dec 31, 2016 | 14.35M | 5.69M | 65.66% |
| Dec 31, 2015 | 8.66M | 2.36M | 37.55% |
| Dec 31, 2014 | 6.30M | 1.20M | 23.46% |
| Dec 31, 2013 | 5.10M | 5.06M | 10,977.18% |
| Dec 31, 2012 | 46.06K | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Related Stocks
| Company Name | Revenue |
|---|---|
| Arbutus Biopharma | 181.72M |
| Kura Oncology | 77.23M |
| Monte Rosa Therapeutics | 28.73M |
| Janux Therapeutics | 24.00M |
| Attovia Therapeutics | 1.35M |
| Avalo Therapeutics | 59.00K |
IVA News
- 2 days ago - Inventiva Reports Final Patient Visit In Phase 3 NATiV3 Study For Lanifibranor; Topline Data In Q4 - Nasdaq
- 3 days ago - Inventiva announces last patient visit in NATiV3 trial - TheFly
- 4 days ago - Inventiva Names Chris Benecchi As COO Ahead Of Lanifibranor's Phase 3 Readout - Nasdaq
- 5 days ago - Inventiva appoints Chris Benecchi as COO - TheFly
- 5 days ago - Inventiva Appoints Chris Benecchi as Chief Operating Officer - GlobeNewsWire
- 5 weeks ago - Correction: Inventiva Announces Preliminary Financial Results for the First Half of 2026¹ - GlobeNewsWire
- 5 weeks ago - Inventiva Announces Preliminary Financial Results for the First Half of 2026¹ - GlobeNewsWire
- 5 weeks ago - Inventiva Earnings release: Q2 2026 - Filings